Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Streaming Stock Quotes Are
Regeneron Pharmaceuticals Inc
(REGN :
)
Real Time Stock Quote | Source:
Extended Hours
---
Last Trade
---
*
After Hours Change
---
Volume
---
After Hours
---
Last Trade
---
*
Change
---
Volume
---
Trade Time
Symbol :
Go
[Find Symbol]
QUOTE
CHART
NEWS
PROFILE
EARNINGS
PEERS
FINANCIALS
OWNERSHIP
Earnings History
Consensus Recommendations
Peer Earnings
REGN FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
More
Former Oracle Exec Hired At Salesforce.com
07 Jun 2013
Cramer: Out with the New, In with the Old
03 Jun 2013 - CNBC.com
FACTBOX-U.S. biotech shares outpace broader stock market
28 May 2013 - Reuters
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
21 May 2013 - Reuters
Regeneron, Sanofi asthma drug seen as potential game changer
21 May 2013 - Reuters
MORE FROM CNBC
More
Former Oracle Exec Hired At Salesforce.com
07 Jun 2013
Cramer: Out with the New, In with the Old
03 Jun 2013 - CNBC.com
MORE FROM OUR PARTNERS
More
An Interview With Elemer Piros: A Strong Year For Biotechs, Looking Fr...
14 hrs ago - Seeking Alpha
Opko: More Hidden Value In Partnerships, Equity Investments
10 Jun 2013 - Seeking Alpha
5 Stocks To Watch Closely This Week
10 Jun 2013 - Seeking Alpha
OPKO Looks Lucrative As Acquired HGH-CTP Moves Into Phase III Trials
06 Jun 2013 - Seeking Alpha
Regeneron's Blockbuster Drug Eylea And Its Potential Competitors
30 May 2013 - Seeking Alpha
What Is Your Exit Strategy?
30 May 2013 - Seeking Alpha
2 Potentially Explosive Small Cap Stocks For 2013
30 May 2013 - Seeking Alpha
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
28 May 2013 - Seeking Alpha
Cramer's Mad Money - The Miraculous Six Flags (5/22/13)
23 May 2013 - Seeking Alpha
Regeneron Shareholders Watching Optina Trial Closely
22 May 2013 - Seeking Alpha
LATEST TRANSCRIPTS
More
Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual ...
11 Jun 2013 - Seeking Alpha
Regeneron Pharmaceuticals, Inc. Presents at 38th Annual Deutsche Bank ...
29 May 2013 - Seeking Alpha
Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conf...
20 May 2013 - Seeking Alpha
PRESS RELEASES
More
Prize4Life and Knopp Neurosciences Announce Donation of EMPOWER Phase ...
13 Jun 2013 - Business Wire
BioNJ Partners with New Jersey Labor Department to Kick Off Life Scien...
12 Jun 2013 - Business Wire
Cellectis plant sciences CEO Luc Mathis joins Board of Directors of th...
06 Jun 2013 - Business Wire
Regeneron and Bayer Report Positive Phase 3 Results for EYLEA® (aflibe...
06 Jun 2013 - PR Newswire
Acceleron Named to the "Best Places to Work" List by The Scientist Mag...
04 Jun 2013 - Business Wire
Cellectis: Compact TALENTM: the next generation of TAL effector nuclea...
21 May 2013 - Business Wire
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results...
21 May 2013 - PR Newswire
Markets
Economy
Companies
Top News & ANALYSIS
Good News for Softbank: Dish Abandons Sprint Bid
Even Fed May Not Be Able to Tame Volatile Trading
Google Facilitates Illegal Activity, Say State AGs
Fast Money Traders: 'Full-Speed Ahead' Before Fed
Adobe Outlook 'Pretty Impressive': Analyst
United Elite Status? Depends on How Much You Spend
Icahn Proposes Tender for 1.1 Billion Dell Shares
NYSE Bomb Plot Foiled by Surveillance Program: FBI
Home Builders Slow New Construction, Raise Prices
Forgot to 'Google' Your Financial Advisor?
SPECIAL OFFER
Download Free Annual Report.